This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.
The drug SYSCAN contains one active pharmaceutical ingredient (API):
1
|
UNII
8VZV102JFY - FLUCONAZOLE
|
|
Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-2126 | Capsule | Syscan 50 mg Capsules CAP 50 mg | Each capsule contains: Fluconazole BP 50 mg | 24/06/2021 |
| B4-2127 | Capsule | Syscan Capsules 150 mg CAP 150 mg | 01/03/2021 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 60609, 60610 |
| NG | Registered Drug Product Database | B4-2126, B4-2127 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.